Package Leaflet: Information for the User
Ezetimibe/Atorvastatin pensa 10 mg/20 mg Film-Coated Tablets
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
Ezetimibe/Atorvastatin pensa is a medication that decreases high levels of cholesterol. Ezetimibe/Atorvastatin pensa contains ezetimibe and atorvastatin.
Ezetimibe/Atorvastatin is used in adults to decrease total cholesterol, "bad" cholesterol (low-density lipoprotein, LDL) and certain fatty substances called triglycerides that circulate in the blood. Additionally, this medication increases the concentrations of "good" cholesterol (high-density lipoprotein, HDL).
Ezetimibe/Atorvastatin acts by reducing cholesterol in two ways. It reduces the cholesterol absorbed in the digestive tract, as well as the cholesterol that your body produces on its own.
Cholesterol is one of the fatty substances that are found in the circulatory system. Your total cholesterol is composed mainly of LDL and HDL cholesterol.
LDL cholesterol is often referred to as "bad" cholesterol because it can accumulate in the walls of your arteries, forming plaques. Over time, this accumulation of plaque can cause a narrowing of the arteries. This narrowing can make the blood flow to vital organs such as the heart and brain slower or interrupted. This interruption of blood flow can trigger a myocardial infarction or a stroke.
HDL cholesterol is often referred to as "good" cholesterol because it helps to prevent the accumulation of bad cholesterol in the arteries and protects them from cardiovascular diseases.
Triglycerides are another type of fat present in your blood that can increase the risk of cardiovascular disease.
This medication is used in patients who cannot control their cholesterol levels solely with diet. While taking this medication, you should follow a cholesterol-lowering diet.
This medication is used, along with a cholesterol-lowering diet, if you have:
Ezetimibe/Atorvastatindoes not help you lose weight.
Do not take Ezetimiba/Atorvastatina if you think
Warnings and precautions
Consult your doctor or pharmacist before starting to take ezetimiba/atorvastatina.
Contact your doctor as soon as possible if you experience unexplained muscle pain, sensitivity, or muscle weakness while taking Ezetimiba/Atorvastatina.This is because, in rare cases, muscle problems can be severe, including muscle rupture causing kidney damage. It is known that atorvastatina causes muscle problems and muscle problems have also been reported with ezetimiba.
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and additional medicines may be needed to diagnose and treat this problem.
Consult your doctor or pharmacist before starting to take this medicine:
-if you have severe respiratory failure.
If you find yourself in any of the above circumstances (or are unsure), consult your doctor before starting to take ezetimiba/atorvastatina, as your doctor will need to take a blood test before starting your treatment with ezetimiba/atorvastatina, and possibly during it, to predict the risk of you experiencing adverse muscle effects. It is known that the risk of experiencing adverse muscle effects, e.g. rhabdomyolysis, increases when certain medicines are taken simultaneously (see section 2 “Warnings and precautions”).
While you are taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in your blood, are overweight and have high blood pressure.
Inform your doctor of all your medical problems, including allergies.
You should avoid the combined use of ezetimiba/atorvastatina and fibrates (certain medicines to reduce cholesterol), as the combined use of ezetimiba/atorvastatina and fibrates has not been studied.
Children
Ezetimiba/atorvastatina is not recommended for children and adolescents.
Other medicines and Ezetimiba/Atorvastatina pensa
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine, including over-the-counter medicines.
There are some medicines that may modify the effect of ezetimiba/atorvastatina or whose effects may be affected by ezetimiba/atorvastatina (see section 3). This type of interaction may reduce the effectiveness of one or both medicines. On the other hand, it may also increase the risk or severity of adverse effects, including a serious condition in which muscle is destroyed, known as “rhabdomyolysis”, which is described in section 4:
** If you have to take fusidic acid orally to treat a bacterial infection, you will temporarily have to stop taking this medicine. Your doctor will tell you when you can restart your treatment with ezetimiba/atorvastatina. The use of ezetimiba/atorvastatina with fusidic acid rarely may cause muscle weakness, sensitivity or pain (rhabdomyolysis). For more information on rhabdomyolysis, see section 4.
Other medicines that are known to interact with ezetimiba/atorvastatina
Taking Ezetimiba/Atorvastatina pensa with food and alcohol
See section 3 for instructions on how to take ezetimiba/atorvastatina. Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day, as large amounts of orange juice may alter the effects of ezetimiba/atorvastatina.
Alcohol
Avoid excessive alcohol consumption while taking this medicine. For more details, see section 2 “Warnings and precautions”.
Pregnancy and breastfeeding
Do not take ezetimiba/atorvastatina if you are pregnant, trying to become pregnant or breastfeeding.
If you become pregnant while taking ezetimiba/atorvastatina, stop taking it immediately and inform your doctor.
Do not take ezetimiba/atorvastatina if you are breastfeeding.
The safety of ezetimiba/atorvastatina during pregnancy and breastfeeding has not been proven.
Consult your doctor or pharmacist before taking this medicine.
Driving and operating machines
Ezetimiba/atorvastatina is not expected to interfere with your ability to drive or use machines. However, some people may experience dizziness after taking ezetimiba/atorvastatina.
Ezetimiba/Atorvastatina pensa contains lactose
The tablets of ezetimiba/atorvastatina contain a sugar called lactose. If your doctor has told you that you are intolerant to certain sugars, consult your doctor before taking this medicine.
Ezetimiba/Atorvastatina pensa contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; that is, it is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. Your doctor will determine the appropriate dose per tablet for you, depending on your current treatment and personal risk situation. In case of doubt, consult your doctor or pharmacist again.
What quantity should you take
The recommended dose is one tablet ofezetimiba/atorvastatinaonce a day taken orally.
Form of administration
Takeezetimiba/atorvastatinaat any time of the day. You can take it with or without food.
If your doctor has prescribedezetimiba/atorvastatinaalong with cholestyramine or any other bile acid sequestrant (medications that reduce cholesterol levels), you should takeezetimiba/atorvastatinaat least 2 hours before or 4 hours after taking the bile acid sequestrant.
If you take more Ezetimiba/Atorvastatina pensa than you should
Consult with your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Ezetimiba/Atorvastatina pensa
Do not take an extra dose; the next day, take your normal dose of ezetimiba/atorvastatina at the usual time. If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following serious side effects or symptoms, stop taking your tablets and immediately inform your doctor, or go to the nearest hospital emergency service.
Consult your doctor as soon as possible if you experience problems associated with the unexpected or unusual appearance of bleeding or bruising, as this may be indicative of liver disease.
The following side effects were frequently reported (may affect up to 1 in 10 patients):
The following side effects were infrequently reported (may affect up to 1 in 100 patients):
In addition, the following side effects have been reported in patients taking ezetimiba/atorvastatina, ezetimiba, or atorvastatina tablets:
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Possible side effects reported with some statins
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaRAM.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging or on the container after “CAD” or “EXP”. The expiration date is the last day of the month indicated.
This medication does not require special conditions for conservation.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Ezetimiba/Atorvastatina pensa
The active principles are ezetimiba and atorvastatina. Each film-coated tablet contains 10 mg of ezetimiba and 20 mg of atorvastatina (as atorvastatina calcium trihydrate).
The other components are: calcium carbonate; anhydrous colloidal silica; sodium croscarmellose; hydroxypropylcellulose; lactose monohydrate; povidone; magnesium stearate; microcrystalline cellulose; polisorbate 80; sodium laurylsulfate (E487).
The tablet coating contains: hypromellose, lactose monohydrate, macrogol titanium dioxide, talc.
Appearance of the product and content of the packaging
Film-coated tablets, capsule-shaped, biconvex, and white to off-white in color, with "2T" engraved on one face.
Packaging sizes:
Packages of 30 film-coated tablets in aluminum/aluminum blisters.
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Responsible for manufacturing:
Delorbis Pharmaceuticals Ltd.
17 Athinon Street
Ergates Industrial Area
2643 Ergates Lefkosia
Cyprus
This medicine is authorized in the member states of the European Economic Area with the following names:
Spain: Ezetimiba/Atorvastatina pensa 10 mg/20 mg film-coated tablets EFG
Netherlands: Ezetimibe/Atorvastatine Tiefenbacher 10 mg/20 mg filmomhulde tabletten
Revision date of this leaflet: 12/2023
Further information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.